Page last updated: 2024-11-02

piracetam and Atrophy

piracetam has been researched along with Atrophy in 4 studies

Piracetam: A compound suggested to be both a nootropic and a neuroprotective agent.

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research Excerpts

ExcerptRelevanceReference
"We describe a patient with cerebellar ataxia of degenerative nature who was administered high-dose piracetam in a single-blind trial."9.10High-dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy. ( Altinel, A; Apaydin, H; Ozekmekçi, S; Vural, M, 2003)
"We describe a patient with cerebellar ataxia of degenerative nature who was administered high-dose piracetam in a single-blind trial."5.10High-dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy. ( Altinel, A; Apaydin, H; Ozekmekçi, S; Vural, M, 2003)
"Levetiracetam (LEV) treatment was started in combination with VPA in a patient with typical clinical, histological, and biochemical features of MERRF due to a mutation on the tRNA of Phenilalanine gene."1.33Antimyoclonic effect of levetiracetam in MERRF syndrome. ( Filosto, M; Galli, R; Mancuso, M; Murri, L; Pizzanelli, C; Siciliano, G, 2006)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (50.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lv, Y1
Zhang, N1
Liu, C1
Shi, M1
Sun, L1
Abourazzak, S1
Chaouki, S1
Boubou, M1
Amrani, M1
Atmani, S1
Hida, M1
Vural, M1
Ozekmekçi, S1
Apaydin, H1
Altinel, A1
Mancuso, M1
Galli, R1
Pizzanelli, C1
Filosto, M1
Siciliano, G1
Murri, L1

Trials

1 trial available for piracetam and Atrophy

ArticleYear
High-dose piracetam is effective on cerebellar ataxia in patient with cerebellar cortical atrophy.
    Movement disorders : official journal of the Movement Disorder Society, 2003, Volume: 18, Issue:4

    Topics: Adult; Atrophy; Cerebellar Ataxia; Cerebellar Cortex; Dose-Response Relationship, Drug; Female; Huma

2003

Other Studies

3 other studies available for piracetam and Atrophy

ArticleYear
Occipital epilepsy versus progressive myoclonic epilepsy in a patient with continuous occipital spikes and photosensitivity in electroencephalogram: A case report.
    Medicine, 2018, Volume: 97, Issue:15

    Topics: Anticonvulsants; Atrophy; Cerebral Cortex; Diagnosis, Differential; Disease Progression; Electroence

2018
[Involuntary movements in infantile cobalamin deficiency appearing during treatment].
    Presse medicale (Paris, France : 1983), 2013, Volume: 42, Issue:4 Pt 1

    Topics: Anemia, Megaloblastic; Atrophy; Brain; Consanguinity; Electroencephalography; Female; Humans; Hydrox

2013
Antimyoclonic effect of levetiracetam in MERRF syndrome.
    Journal of the neurological sciences, 2006, Apr-15, Volume: 243, Issue:1-2

    Topics: Activities of Daily Living; Anticonvulsants; Atrophy; Brain; Drug Therapy, Combination; Female; Gene

2006